381 related articles for article (PubMed ID: 31987990)
1. Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure.
Engelmann C; Sheikh M; Sharma S; Kondo T; Loeffler-Wirth H; Zheng YB; Novelli S; Hall A; Kerbert AJC; Macnaughtan J; Mookerjee R; Habtesion A; Davies N; Ali T; Gupta S; Andreola F; Jalan R
J Hepatol; 2020 Jul; 73(1):102-112. PubMed ID: 31987990
[TBL] [Abstract][Full Text] [Related]
2. Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF.
Engelmann C; Habtesion A; Hassan M; Kerbert AJ; Hammerich L; Novelli S; Fidaleo M; Philips A; Davies N; Ferreira-Gonzalez S; Forbes SJ; Berg T; Andreola F; Jalan R
J Hepatol; 2022 Nov; 77(5):1325-1338. PubMed ID: 35843375
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Alkaline Phosphatase Prevents Acute on Chronic Liver Failure.
Engelmann C; Adebayo D; Oria M; De Chiara F; Novelli S; Habtesion A; Davies N; Andreola F; Jalan R
Sci Rep; 2020 Jan; 10(1):389. PubMed ID: 31942020
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.
Gehrke N; Hövelmeyer N; Waisman A; Straub BK; Weinmann-Menke J; Wörns MA; Galle PR; Schattenberg JM
J Hepatol; 2018 May; 68(5):986-995. PubMed ID: 29366909
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
Zhang S; Yang N; Ni S; Li W; Xu L; Dong P; Lu M
Int J Clin Exp Pathol; 2014; 7(10):6626-34. PubMed ID: 25400741
[TBL] [Abstract][Full Text] [Related]
6. Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats.
Kitazawa T; Tsujimoto T; Kawaratani H; Fukui H
J Gastroenterol Hepatol; 2010 May; 25(5):1009-12. PubMed ID: 20546456
[TBL] [Abstract][Full Text] [Related]
7. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
Ben Ari Z; Avlas O; Pappo O; Zilbermints V; Cheporko Y; Bachmetov L; Zemel R; Shainberg A; Sharon E; Grief F; Hochhauser E
Cell Physiol Biochem; 2012; 29(1-2):41-50. PubMed ID: 22415073
[TBL] [Abstract][Full Text] [Related]
8. [Experimental study on the inhibition of the NLRP3 signaling pathway with Shengsan Jiedu Huayu decoction to alleviate inflammatory injury in rats with acute-on-chronic liver failure].
Liu X; Meng JL; Wang MG; Mao DW; Dai M
Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):354-362. PubMed ID: 38733191
[No Abstract] [Full Text] [Related]
9. Ligustrazine disrupts lipopolysaccharide-activated NLRP3 inflammasome pathway associated with inhibition of Toll-like receptor 4 in hepatocytes.
Zhang F; Jin H; Wu L; Shao J; Wu X; Lu Y; Zheng S
Biomed Pharmacother; 2016 Mar; 78():204-209. PubMed ID: 26898443
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
Tripathi DM; Vilaseca M; Lafoz E; Garcia-Calderó H; Viegas Haute G; Fernández-Iglesias A; Rodrigues de Oliveira J; García-Pagán JC; Bosch J; Gracia-Sancho J
Gastroenterology; 2018 Nov; 155(5):1564-1577. PubMed ID: 30055171
[TBL] [Abstract][Full Text] [Related]
11. BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats.
Lu L; Wu C; Lu BJ; Xie D; Wang Z; Bahaji Azami NL; An YT; Wang HJ; Ye G; Sun MY
J Ethnopharmacol; 2020 Mar; 249():112301. PubMed ID: 31622746
[TBL] [Abstract][Full Text] [Related]
12. Calycosin inhibits hepatocyte apoptosis in acute liver failure by suppressing the TLR4/NF-κB pathway: An in vitro study.
Chang L; Zhang A; Liu W; Cao P; Dong L; Gao X
Immun Inflamm Dis; 2023 Jul; 11(7):e935. PubMed ID: 37506138
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model.
Sha T; Sunamoto M; Kitazaki T; Sato J; Ii M; Iizawa Y
Eur J Pharmacol; 2007 Oct; 571(2-3):231-9. PubMed ID: 17632100
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of glycogen synthase kinase 3β ameliorates D-GalN/LPS-induced liver injury by reducing endoplasmic reticulum stress-triggered apoptosis.
Chen L; Ren F; Zhang H; Wen T; Piao Z; Zhou L; Zheng S; Zhang J; Chen Y; Han Y; Duan Z; Ma Y
PLoS One; 2012; 7(9):e45202. PubMed ID: 23028846
[TBL] [Abstract][Full Text] [Related]
15. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of oxymatrine on hepatocyte apoptosis
Zhang X; Jiang W; Zhou AL; Zhao M; Jiang DR
World J Gastroenterol; 2017 Jun; 23(21):3839-3849. PubMed ID: 28638224
[TBL] [Abstract][Full Text] [Related]
17. Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation.
Monteiro S; Grandt J; Uschner FE; Kimer N; Madsen JL; Schierwagen R; Klein S; Welsch C; Schäfer L; Jansen C; Claria J; Alcaraz-Quiles J; Arroyo V; Moreau R; Fernandez J; Bendtsen F; Mehta G; Gluud LL; Møller S; Praktiknjo M; Trebicka J
Gut; 2021 Feb; 70(2):379-387. PubMed ID: 32241903
[TBL] [Abstract][Full Text] [Related]
18. Synthetic anti-endotoxin peptides inhibit cytoplasmic LPS-mediated responses.
Pfalzgraff A; Heinbockel L; Su Q; Brandenburg K; Weindl G
Biochem Pharmacol; 2017 Sep; 140():64-72. PubMed ID: 28539262
[TBL] [Abstract][Full Text] [Related]
19. A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling.
Ii M; Matsunaga N; Hazeki K; Nakamura K; Takashima K; Seya T; Hazeki O; Kitazaki T; Iizawa Y
Mol Pharmacol; 2006 Apr; 69(4):1288-95. PubMed ID: 16373689
[TBL] [Abstract][Full Text] [Related]
20. Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK.
Bernsmeier C; Pop OT; Singanayagam A; Triantafyllou E; Patel VC; Weston CJ; Curbishley S; Sadiq F; Vergis N; Khamri W; Bernal W; Auzinger G; Heneghan M; Ma Y; Jassem W; Heaton ND; Adams DH; Quaglia A; Thursz MR; Wendon J; Antoniades CG
Gastroenterology; 2015 Mar; 148(3):603-615.e14. PubMed ID: 25479139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
